Document:

unis-ex102_810.htm

 

Exhibit 10.2

Third AMENDMENT TO Royalty AGREEMENT 

This Third AMENDMENT TO Royalty AGREEMENT (this “Amendment”) is effective as of January 29, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (“Unilife”) and Royalty OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”).

WHEREAS, Unilife and ROS are party to that certain Royalty Agreement, dated as of March 12, 2014 (as amended from time to time, the “Royalty Agreement”), pursuant to which Unilife granted to ROS a royalty on the terms set forth therein;

WHEREAS, Unilife and ROS Acquisition Offshore LP, a Cayman Islands exempted limited partnership (the “Lender”) are party to that certain Credit Agreement, dated as of March 12, 2014 (as amended from time to time, the “Credit Agreement”), pursuant to which the Lender has extended credit to Unilife on the terms set forth therein; and

WHEREAS, Unilife and ROS have agreed to amend the Royalty Agreement, upon the terms and subject to the conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1. Definitions; Loan Document.  Capitalized terms used herein without definition shall have the meanings assigned to such terms in the Royalty Agreement and, to the extent not defined therein, in the Credit Agreement.  This Amendment shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents.  Each reference to “hereof”, “hereunder”, “herein” and “hereby” and each other similar reference and each reference to “this Agreement” and each other similar reference contained in the Royalty Agreement shall, after this Amendment becomes effective, refer to the Royalty Agreement as amended hereby.

2. Amendments.  Section 2.1(b) of the Royalty Agreement is hereby amended by adding the following language at the end of the first sentence thereof (prior to the period): 

; provided further that $124,749.81 of the Royalty Payment for the Fiscal Quarter ending December 31, 2015 shall be due and payable on February 1, 2016 and $678,150.00 of the Royalty Payment for the Fiscal Quarter ending December 31, 2015 shall be due and payable on February 9, 2016

3. Conditions to Effectiveness of Amendment.  This Amendment shall become effective upon receipt (i) by ROS of a counterpart signature to this Amendment duly executed and delivered by Unilife, and (ii) by ROS or its counsel of reimbursement for all fees and out-of-pocket expenses incurred by ROS in connection with this Amendment and all other like expenses remaining unpaid as of the date hereof. 

 

 

4. Expenses.  Unilife agrees to pay on demand all expenses of ROS (including, without limitation, the fees and out-of-pocket expenses of Covington & Burling LLP, counsel to ROS, and of local counsel, if any, who may be retained by or on behalf of ROS) incurred in connection with the negotiation, preparation, execution and delivery of this Amendment and all other expenses of ROS remaining unpaid as of the date hereof.

5. Representations and Warranties.  Unilife represents and warrants to ROS as follows:

(a) After giving effect to this Amendment, the representations and warranties of Unilife contained in the Royalty Agreement (other than Section 6.14 of the Credit Agreement) shall, except as disclosed in the disclosure letter dated the date hereof and delivered to the Lender on the date hereof (i) with respect to representations and warranties that contain a materiality qualification, be true and correct in all respects on and as of the date hereof, and (ii) with respect to representations and warranties that do not contain a materiality qualification, be true and correct in all material respects on and as of the date hereof, and except that the representations and warranties limited by their terms to a specific date shall be true and correct as of such date.

(b) After giving effect to this Amendment, no Royalty Event of Default has occurred or is continuing.

(c) (i) Unilife has taken all necessary action to authorize the execution, delivery and performance of this Amendment; (ii) this Amendment has been duly executed and delivered by Unilife and constitutes Unilife’s legal, valid and binding obligation, enforceable in accordance with its terms (except, in any case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally and by principles of equity), and (iii) no authorization or other action by, and no notice to or filing with, any Governmental Authority or other Person is required for the due execution, delivery or performance by Unilife of this Amendment.

6. No Implied Amendment or Waiver.  Except as expressly set forth in this Amendment, this Amendment shall not, by implication or otherwise, limit, impair, constitute a waiver of or otherwise affect any rights or remedies of ROS under the Royalty Agreement or the other Loan Documents, or alter, modify, amend or in any way affect any of the terms, obligations or covenants contained in the Royalty Agreement or the other Loan Documents, all of which shall continue in full force and effect.  Nothing in this Amendment shall be construed to imply any willingness on the part of ROS to agree to or grant any similar or future amendment, consent or waiver of any of the terms and conditions of the Royalty Agreement or the other Loan Documents.

7. Reaffirmation of Security Interests.  The Credit Obligors (i) affirm that each of the security interests and liens granted in or pursuant to the Loan Documents are valid and subsisting and (ii) agree that this Amendment shall in no manner impair or otherwise adversely affect any of the security interests and liens granted in or pursuant to the Loan Documents. 

 

 

8. Reaffirmation of Guarantee.  Each Guarantor (a) acknowledges and consents to all of the terms and conditions of this Amendment, (b) affirms all of its obligations under the Loan Documents and (c) agrees that this Amendment and all documents executed in connection herewith do not operate to reduce or discharge the Guarantor’s obligations under the Loan Documents.

9. Waiver and Release.  TO INDUCE ROS TO AGREE TO THE TERMS OF THIS AMENDMENT, Unilife REPRESENTS AND WARRANTS THAT AS OF THE DATE HEREOF THERE ARE NO CLAIMS OR OFFSETS AGAINST OR RIGHTS OF RECOUPMENT WITH RESPECT TO OR DEFENSES OR COUNTERCLAIMS TO ITS OBLIGATIONS UNDER THE LOAN DOCUMENTS AND IN ACCORDANCE THEREWITH IT:

(a) WAIVES ANY AND ALL SUCH CLAIMS, OFFSETS, RIGHTS OF RECOUPMENT, DEFENSES OR COUNTERCLAIMS, WHETHER KNOWN OR UNKNOWN, ARISING PRIOR TO THE DATE HEREOF; AND

(b) RELEASES AND DISCHARGES ROS, ITS AFFILIATES AND ITS AND THEIR OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, SHAREHOLDERS AND ATTORNEYS (COLLECTIVELY THE “RELEASED PARTIES”) FROM ANY AND ALL OBLIGATIONS, INDEBTEDNESS, LIABILITIES, CLAIMS, RIGHTS, CAUSES OF ACTION OR DEMANDS WHATSOEVER, WHETHER KNOWN OR UNKNOWN, SUSPECTED OR UNSUSPECTED, IN LAW OR EQUITY, WHICH Unilife EVER HAD, NOW HAS, CLAIMS TO HAVE OR MAY HAVE AGAINST ANY RELEASED PARTY ARISING PRIOR TO THE DATE HEREOF AND FROM OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY.

10. Counterparts; Governing Law.  This Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of such when so executed and delivered shall be an original, but all of such counterparts shall together constitute but one and the same agreement.  Delivery of an executed counterpart of a signature page of this Amendment by fax transmission or other electronic mail transmission (e.g., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this Amendment.  THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK).

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized on January 31, 2016.

 

	
Unilife Medical Solutions, Inc.
	
 
	
Unilife Medical Solutions, Inc.

	
 
	
 
	
 

	
By:
	
 
	
/s/ John Ryan
	
 
	
By:
	
 
	
 

	
 
	
 
	
Name:  John Ryan
	
 
	
 
	
 
	
Name:

	
 
	
 
	
Title:    Senior Vice President, General 
	
 
	
 
	
 
	
Title:

	
 
	
 
	
Counsel and Secretary
	
 
	
 
	
 
	
 

	
 
	
 
	
 

	
ROYALTY OPPORTUNITIES S.À R.L
	
 
	
ROYALTY OPPORTUNITIES S.À R.L

	
By OrbiMed Advisors LLC, its investment manager
	
 
	
By OrbiMed Advisors LLC, its investment manager

	
 
	
 
	
 

	
By:
	
 
	
/s/ Samuel D. Isaly
	
 
	
By:
	
 
	
 

	
 
	
 
	
Name:  Samuel D. Isaly
	
 
	
 
	
 
	
Name:

	
 
	
 
	
Title:    Managing Member
	
 
	
 
	
 
	
Title:

 

Signature Page to Third Amendment to Royalty Agreement

 

Acknowledged and agreed:

EXECUTED as a deed by each Australian Subsidiary

 

	
Unilife Cross Farm LLC
	
 
	
Unilife Corporation

	
 
	
 
	
 
	
 
	
 
	
 
	
 

	
By:
	
 
	
/s/ John Ryan
	
 
	
By:
	
 
	
/s/ John Ryan

	
 
	
 
	
Name:   John Ryan
	
 
	
 
	
 
	
Name:   John Ryan

	
 
	
 
	
Title:     Senior Vice President, General
	
 
	
 
	
 
	
Title:     Senior Vice President, General

	
 
	
 
	
Counsel and Secretary
	
 
	
 
	
 
	
Counsel and Secretary

 

	
Executed by Unilife Medical Solutions Pty Limited in accordance with Section 127 of the Corporations Act 2001
	
 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 
	
 

	
/s/ Alan Shortall
	
 
	

	
 
	
/s/ Ramin Mojdeh
	

	
Signature of director
	
 
	
 
	
 
	
Signature of director/company secretary
	
 

	
 
	
 
	
 
	
 
	
(please delete as applicable)
	
 

	
 
	
 
	
 
	
 
	
 
	
 

	
Alan Shortall
	
 
	
 
	
 
	
Ramin Mojdeh
	
 

	
Name of director (print)
	
 
	
 
	
 
	
Name of director/company secretary (print)
	
 

 

	
Executed by Unitract Syringe Pty Ltd in accordance with Section 127 of the Corporations Act 2001
	
 
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 
	
 

	
/s/ Alan Shortall
	
 
	

	
 
	
/s/ Ramin Mojdeh
	

	
Signature of director
	
 
	
 
	
 
	
Signature of director/company secretary
	
 

	
 
	
 
	
 
	
 
	
(please delete as applicable)
	
 

	
 
	
 
	
 
	
 
	
 
	
 

	
Alan Shortall
	
 
	
 
	
 
	
Ramin Mojdeh
	
 

	
Name of director (print)
	
 
	
 
	
 
	
Name of director/company secretary (print)
	
 

 

Signature Page to Third Amendment to Royalty Agreementunis-ex103_932.htm

Exhibit 10.3

January 31, 2016

Amgen Inc.

One Amgen Center Drive

Thousand Oaks  CA  91320-1799

Attention:  Corporate Secretary

Re:    Amendment of Exclusivity Letter

Ladies and Gentlemen:

Unilife Corporation (“Unilife”) and Amgen Inc. (“Amgen” and, together with Unilife, the “Parties”) have entered into an exclusivity letter agreement dated December 31, 2015 (the “Exclusivity Letter”).  Capitalized terms used but not defined in this letter shall have the meanings assigned to such terms in the Exclusivity Letter.

Pursuant to Section 13 of the Exclusivity Letter, the Parties intend to hereby amend the Exclusivity Letter, and agree that the Exclusivity Period in Section 1(a) of the Exclusivity Letter shall be extended through and to 11:59 pm Pacific Time on Friday, February 5, 2016 so long as the Parties continue to negotiate in good faith a Transaction. 

 

	
Very truly yours,

	
 
	
 
	
 

	
UNILIFE CORPORATION

	
 
	
 
	
 

	
By:
	
 
	
/s/ John Ryan

	
Name:
	
 
	
John Ryan

	
Title:
	
 
	
SVP, General Counsel & Secretary

 

CONFIRMED AND AGREED TO:

AMGEN INC.

 

	
By:
	
 
	
/s/ David A. Piacquad

	
Name:
	
 
	
David A. Piacquad

	
Title:
	
 
	
Senior Vice President,

Business Development

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}]]